Volume 1 Issue 3

2017-12-05 Case Report

Near Complete Response to 177Lu- PSMA-DKFZ-617 Therapy in a Patient with Metastatic Castration Resistant Prostate Cancer

Prostate specific membrane antigen, a type II transmembrane protein is an excellent target for the radionuclide therapy in advanced prostate cancer patients due to its high expression in the prostate cancer cells.

Read Full Article HTML DOI: 10.29328/journal.jro.1001012 Citation

2017-10-17 Review Article

Hyperthermia and Breast cancer: A short review

The main goal of hyperthermia is to elevate the tumor temperature to kill tumor cells and improve local control. The usage of hyperthermia is combination with radiotherapy or chemotherapy. Hyperthermia is
delivered in different types of cancers like breast cancer, melanoma and sarcoma....

Read Full Article HTML DOI: 10.29328/journal.jro.1001011 Citation

2017-09-27 Review Article

Ra-223 dichloride management in a Nuclear Medicine Unit: experience of a referral institution

Ra-223 dichloride is a first-in-class alpha-emitting radiopharmaceutical recently introduced into clinical practice for treatment of men with Castration-Resistant Prostate Cancer (CRPC) and symptomatic bone metastases.

Read Full Article HTML DOI: 10.29328/journal.jro.1001010 Citation

Recent Articles

2018-07-28 Research Article

Clinically and Radiological isolated syndrome (MS risk)

Hashem HA, Mustafa YH, Reda AM, Azab S, Solaiman AM

Read Full Article HTML DOI: 10.29328/journal.jro.1001020 Citation

2018-07-28 Case Report

Incidental findings in traditional nuclear medicine practice

De Vincentis G, Pontico M, Ricci M, Frantellizzi V, Liberatore M

Read Full Article HTML DOI: 10.29328/journal.jro.1001019 Citation